Cargando…
Using multicriteria decision analysis during drug development to predict reimbursement decisions
BACKGROUND: Pharmaceutical companies design clinical development programs to generate the data that they believe will support reimbursement for the experimental compound. OBJECTIVE: The objective of the study was to present a process for using multicriteria decision analysis (MCDA) by a pharmaceutic...
Autores principales: | Williams, Paul, Mauskopf, Josephine, Lebiecki, Jake, Kilburg, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956287/ https://www.ncbi.nlm.nih.gov/pubmed/29785248 http://dx.doi.org/10.3402/jmahp.v2.25270 |
Ejemplares similares
-
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
por: de Andrés-Nogales, Fernando, et al.
Publicado: (2021) -
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
por: Elvira, David, et al.
Publicado: (2021) -
Multicriteria methodology for decision aiding
por: Roy, Bernard
Publicado: (1996) -
Multicriteria decision making and differential
por: Leitmann, George
Publicado: (1976) -
Multicriteria decision aid methods for the prediction of business failure
por: Zopounidis, Constantin, et al.
Publicado: (1998)